Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

4.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

1.7K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.7K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.9K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

1.2K
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
1.2K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

626
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
626
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

787
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
787

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Introduction to the Bridging Cardiovascular and Kidney Health Series.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Renal Recovery Patterns and Long-Term Kidney Function Decline in Pulmonary Hypertension.

Pulmonary circulation·2026
Same author

Gaps, Barriers, and Facilitators to Implementing Comprehensive Medication Management in Cardiovascular-Kidney-Metabolic Care: A Qualitative Study.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

A Framework for Risk-Based Implementation of Combination Therapy in CKD: Who, Why, When, and How?

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Systematic examination of the PREVENT equations for cardiovascular disease risk.

American journal of preventive cardiology·2026
Same author

2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Journal of the American College of Cardiology·2026

Related Experiment Video

Updated: May 3, 2026

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
04:20

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure

Published on: October 1, 2019

5.1K

Kidney Dysfunction in Heart Failure: Core Curriculum 2025.

Kevin Bryan Lo1, Arun Janakiraman2, Janani Rangaswami3

  • 1Division of Cardiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|May 17, 2025
PubMed
Summary

Heart failure (HF) and kidney dysfunction involve harmful bidirectional pathways. Optimizing decongestion and guideline-directed therapies is crucial for improving outcomes in these high-risk patients.

Keywords:
Cardiorenal syndromechronic kidney diseasedecongestiondiuresisdiuretic resistanceguideline-directed medical therapiesheart failurenatriuresis

More Related Videos

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

6.8K
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

2.0K

Related Experiment Videos

Last Updated: May 3, 2026

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
04:20

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure

Published on: October 1, 2019

5.1K
A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

6.8K
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

2.0K

Area of Science:

  • Cardiology
  • Nephrology
  • Translational Medicine

Background:

  • Heart failure (HF) and kidney dysfunction share complex, bidirectional pathophysiological pathways.
  • Suboptimal management, including poor decongestion and underutilization of guideline-directed medical therapy (GDMT), exacerbates poor cardiovascular and kidney outcomes in patients with coexisting HF and kidney dysfunction.
  • Diuretic resistance is a significant challenge, contributing to persistent congestion and adverse events.

Purpose of the Study:

  • To highlight the interconnected pathophysiology of heart failure and kidney dysfunction.
  • To emphasize the importance of optimizing decongestion strategies and guideline-directed medical therapies in this patient population.
  • To underscore the need for integrated management approaches to improve patient outcomes.

Main Methods:

  • Review of current understanding of the pathophysiology linking heart failure and kidney dysfunction.
  • Analysis of the impact of suboptimal decongestion and diuretic resistance on patient outcomes.
  • Evaluation of the role and benefits of guideline-directed medical therapies in managing patients with comorbid HF and kidney dysfunction.

Main Results:

  • Bidirectional organ dysfunction significantly worsens prognosis in patients with heart failure and kidney dysfunction.
  • Effective decongestion and management of diuretic resistance are critical for mitigating adverse events.
  • Guideline-directed medical therapies demonstrate efficacy in reducing mortality, hospitalizations, and kidney function decline, while improving quality of life.

Conclusions:

  • Integrated and personalized strategies for decongestion are essential for managing patients with heart failure and kidney dysfunction.
  • Optimizing the implementation of evidence-based therapies is key to modifying the disease trajectory and reducing adverse outcomes.
  • Addressing the interplay between heart failure and kidney dysfunction requires a combined approach to improve survival and quality of life in this high-risk group.